Document Classification

Section Type: RESULTS

Text: In the tamsulosin + tolterodine group, IPSS and QOL were decreased from 20. 90 + / - 5. 15 and 4. 61 + / - 0. 86 at the baseline to 14. 90 + / - 5. 32 and 2. 12 + / - 0. 87 after the medication (P < 0. 05), Qmax was increased from (13. 30 + / - 7. 80) ml/s to (16. 70 + / - 6. 32) ml/s (P < 0. 05), and the score on the urinary storage phase symptoms was reduced from 10. 12 + / - 3. 10 to 4. 77 + / - 0. 75 (P < 0. 05).